about
Antithrombotic treatment after intracerebral haemorrhageThrombolysis for acute ischaemic strokeRecanalisation therapies for wake-up strokeFactor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillationOral anticoagulants versus antiplatelet therapy for preventing stroke and systemic embolic events in patients with atrial fibrillationSurgical decompression for cerebral oedema in acute ischaemic strokeFactor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillationPercutaneous vascular interventions for acute ischaemic strokePercutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic strokeThrombolysis for acute ischaemic strokePercutaneous vascular interventions for acute ischaemic strokeThrombolysis for acute ischaemic strokeThe benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialRecombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisAre there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin?Anticoagulants for acute ischemic strokeAnticoagulants versus antiplatelet agents for acute ischemic stroke
P50
Q24185972-2F79BA17-8290-4F62-B90A-F5D373333C5CQ24194788-B4A9332A-2D44-489C-8474-5DAF6289218CQ24198986-51453DD6-4617-400F-9306-4F16581C2EB5Q24200497-C2610925-0FB8-4C0E-BF64-F0DB7D055BA9Q24203797-BFD47F20-98C2-4B57-B449-2A3217F2F0C5Q24203893-D55919D5-E517-41BD-9711-567DF633AD43Q24234397-4DF7E313-829B-4E63-A57E-F0549E20F929Q24234478-E55D5112-3AFA-4F47-A1F5-08AA13B479A8Q24234840-564CB99C-6C17-4350-87E1-55ACC373FF7AQ24240067-E498D2CA-4C9C-4D20-8AAE-4D5D8618B7AAQ24242540-31526CF0-80BD-4151-B6FB-9166299152ACQ24247962-3B858C78-6C13-4EE5-A605-22FF9225046BQ24595579-38DA84B2-C847-42C9-9915-DAB57917927BQ24595703-B65B6414-F0B2-4047-AB30-C2F794B685F2Q28194482-4213E89B-B349-4CBB-9768-5F75DBA5831FQ28196189-922447AA-C3BA-4F1F-885A-4AB7A33FFB69Q28196242-CE7B212B-61BD-4F30-8AD1-8F1870BDB656
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Eivind Berge
@ast
Eivind Berge
@en
Eivind Berge
@es
Eivind Berge
@nl
Eivind Berge
@sl
type
label
Eivind Berge
@ast
Eivind Berge
@en
Eivind Berge
@es
Eivind Berge
@nl
Eivind Berge
@sl
prefLabel
Eivind Berge
@ast
Eivind Berge
@en
Eivind Berge
@es
Eivind Berge
@nl
Eivind Berge
@sl
P106
P21
P214
7617148997701359870001
P31
P734
P7859
lccn-ns2012004180